despit
high
similar
canin
respiratori
coronaviru
crcov
bovin
coronaviru
bcov
human
coronaviru
virus
differ
speci
specif
year
believ
share
receptor
specif
util
sialic
acid
cell
surfac
attach
intern
entri
interestingli
care
literatur
analysi
show
virus
inde
bind
cell
surfac
via
sialic
acid
solid
data
moieti
mediat
viru
entri
studi
use
number
techniqu
show
three
virus
inde
abl
bind
sialic
acid
differ
extent
molecul
render
cell
permiss
clinic
strain
other
serv
attach
receptor
crcov
bcov
appear
employ
human
leukocyt
antigen
class
entri
receptor
furthermor
identifi
heparan
sulfat
altern
attach
factor
may
relat
cell
cultur
adapt
ex
vivo
condit
seem
play
signific
role
summar
delin
earli
event
crcov
bcov
entri
systemat
studi
attach
entri
receptor
util
virus
coronavirus
envelop
singlestrand
positivesens
rna
virus
cluster
within
famili
coronavirida
order
nidoviral
infect
wide
varieti
speci
includ
human
livestock
companion
anim
human
usual
caus
mild
moder
respiratori
symptom
although
sever
case
occur
mostli
individu
impair
immun
respons
emerg
sever
acut
respiratori
syndrom
coronaviru
sarscov
china
winter
middl
east
respiratori
syndrom
coronaviru
merscov
septemb
remind
us
coronavirus
pose
signific
threat
zoonot
transmiss
common
coronavirida
famili
divid
two
subfamili
letovirina
orthocoronavirina
latter
one
divid
four
generaalpha
beta
gamma
deltabas
degre
nucleotid
similar
current
phylogeni
famili
present
figur
tree
highest
log
shown
percentag
tree
associ
taxa
cluster
togeth
shown
next
branch
initi
tree
heurist
search
obtain
automat
appli
neighborjoin
bionj
algorithm
matrix
pairwis
distanc
estim
use
maximum
composit
likelihood
mcl
approach
select
topolog
superior
log
likelihood
valu
discret
gamma
distribut
use
model
evolutionari
rate
differ
among
site
categori
g
paramet
rate
variat
model
allow
site
evolutionarili
invari
site
tree
drawn
scale
branch
length
measur
number
substitut
per
site
analysi
involv
nucleotid
sequenc
posit
contain
gap
miss
data
elimin
total
posit
final
dataset
evolutionari
analys
conduct
betacoronavirus
highli
variabl
use
number
differ
attach
entri
receptor
gener
believ
virus
genu
attach
glycan
layer
cell
surfac
eg
sialic
acid
sa
heparan
sulfat
hs
second
step
infect
interact
entri
receptor
sever
molecul
propos
serv
includ
carcinoembryon
antigencel
adhes
molecul
murin
hepat
viru
mhv
angiotensinconvert
enzym
sarscov
dipeptidyl
peptidas
merscov
human
leukocyt
antigen
class
hlai
suggest
serv
entri
receptor
discoveri
confirm
subsequ
studi
interestingli
sa
also
report
serv
entri
receptor
specul
play
neglig
role
cell
entri
first
isol
next
common
coronaviru
human
incid
infect
highest
winter
earli
spring
thought
viru
emerg
human
popul
end
centuri
recent
common
ancestor
identifi
interest
number
betacoronavirus
eg
bovin
coronaviru
bcov
canin
coronaviru
crcov
dromedari
camel
coronavirus
close
relat
human
pathogen
suggest
speci
recombin
new
subspeci
emerg
focus
three
close
relat
betacoronavirus
almost
ident
genet
perspect
caus
diseas
differ
host
caus
common
cold
human
bcov
caus
gastrointestin
respiratori
tract
diseas
cattl
crcov
link
kennel
cough
dog
surprisingli
high
resembl
spike
protein
nucleotid
ident
crcov
bcov
crcov
common
among
betacoronavirus
well
crossreact
bcov
antigen
canin
antibodi
infect
bcov
pup
led
us
ask
whether
three
virus
share
receptor
specif
found
sa
hs
serv
attach
factor
three
virus
albeit
differ
extent
howev
sa
essenti
crcov
bcov
infect
serv
entri
receptor
clinic
strain
wherea
crcov
bcov
employ
hlai
atcc
cell
deriv
atcc
ileocec
colorect
adenocarcinoma
maintain
dulbecco
mem
life
technolog
warsaw
poland
supplement
heatinactiv
fetal
bovin
serum
life
technolog
warsaw
poland
penicillin
uml
streptomycin
ciprofloxacin
cell
cultur
c
co
gener
human
airway
epithelium
hae
cultur
primari
cell
isol
patient
tissu
cultur
plastic
bronchial
epitheli
growth
media
begm
medium
week
next
passag
cell
seed
permeabl
transwel
insert
support
mm
confluenc
reach
apic
medium
remov
cell
grown
anoth
week
airliquid
interfac
ali
ali
medium
time
cell
fulli
differenti
form
pseudostratifi
mucociliari
epithelium
crcov
bcov
stock
prepar
infect
cell
atcc
cultur
dulbecco
mem
life
technolog
warsaw
poland
supplement
heatinactiv
fetal
bovin
serum
life
technolog
warsaw
poland
penicillin
uml
streptomycin
c
co
bcov
mebu
strain
bei
resourc
cultur
dulbecco
mem
life
technolog
warsaw
poland
supplement
penicillin
uml
streptomycin
trypsin
c
co
crcov
strain
cultur
dulbecco
mem
life
technolog
warsaw
poland
supplement
penicillin
uml
streptomycin
c
co
stock
collect
day
post
infect
pi
two
freezethaw
cycl
mockinfect
cell
use
control
viru
yield
estim
titrat
accord
reed
muench
formula
obtain
aliquot
store
c
stock
isol
amsterdam
gener
infect
cell
cultur
mem
hank
earl
salt
two
part
hank
mem
one
part
earl
mem
supplement
heatinactiv
fetal
bovin
serum
life
technolog
warsaw
poland
penicillin
uml
streptomycin
c
co
stock
collect
day
pi
two
freezethaw
cycl
mockinfect
cell
use
control
influenza
viru
kilbourn
ha
na
x
apuerto
reassort
gener
infect
mdck
cell
cultur
dulbecco
mem
life
technolog
warsaw
poland
supplement
penicillin
uml
streptomycin
trypsin
c
co
stock
collect
day
pi
two
freezethaw
cycl
mockinfect
cell
use
control
isol
propag
fulli
differenti
hae
cultur
prior
infect
apic
surfac
hae
wash
thrice
pb
inocul
dilut
viral
stock
h
incub
c
unbound
viral
particl
remov
wash
pb
min
c
hae
cultur
maintain
c
day
new
viral
stock
obtain
wash
apic
surfac
pb
viruscontain
medium
concentr
use
amicon
ultra
kda
cutoff
merck
warsaw
poland
subsequ
overlaid
iodixanol
solut
pb
optiprep
medium
sigmaaldrich
poznan
poland
centrifug
g
h
c
follow
centrifug
viruscontain
fraction
overlaid
iodixanol
gradient
centrifug
g
h
c
fraction
collect
gradient
analyz
western
blot
detect
crcov
nucleocapsid
protein
virusenrich
fraction
aliquot
store
c
crcov
nucleocapsid
gene
codon
optim
synthet
clone
petduet
vector
via
bamhi
aatii
site
plasmid
ident
confirm
sequenc
n
protein
express
e
coli
origami
cell
follow
induct
mm
iptg
c
h
protein
purifi
ninitrilotriacet
acid
resin
imac
sepharos
fast
flow
mous
polyclon
antibodi
specif
crcov
n
protein
develop
accord
standard
protocol
sixweekold
balbc
mice
purchas
mossakowski
medic
research
centr
polish
academi
scienc
warsaw
poland
mice
inject
intraperiton
purifi
recombin
protein
dilut
pb
mix
complet
freund
adjuv
sigmaaldrich
poznan
poland
subsequ
anim
immun
perform
weekli
antigen
mix
incomplet
freund
adjuv
sigmaaldrich
poznan
poland
soon
antin
serum
titer
reach
elisa
anim
euthan
blood
collect
cardiac
punctur
antibodi
purifi
serum
affin
chromatographi
captur
select
lckappa
mur
affin
matrix
accord
manufactur
instruct
thermo
fisher
scientif
warsaw
poland
dialyz
steril
pb
cell
lysat
mix
sampl
buffer
tri
ph
sd
mgml
dithiothreitol
dtt
boil
min
afterward
separ
sdspage
electrophoresi
alongsid
pagerul
prestain
protein
size
marker
thermo
fisher
scientif
warsaw
poland
electrotransf
onto
activ
pvdf
membran
membran
block
overnight
c
skim
milk
trisbuff
salin
supplement
tween
anticrcov
n
protein
antibodi
h
follow
horseradish
peroxidas
label
rabbit
antimous
secondari
antibodi
h
dako
swarzewo
poland
use
detect
viru
signal
develop
use
immobilon
western
chemiluminesc
hrp
substrat
millipor
warsaw
poland
hemagglutin
assay
perform
vshape
plate
mous
erythrocyt
suspens
prepar
three
wash
twelveweekold
mous
blood
pb
obtain
mous
erythrocyt
suspens
mix
viral
stock
incub
room
temperatur
h
develop
control
serv
influenza
report
hemagglutin
erythrocyt
bind
sa
therefor
trigger
effect
pictur
acquir
use
canon
eo
camera
viral
stock
except
influenza
use
tcid
influenza
viru
appli
tcid
highest
possibl
titer
obtain
determin
cell
surfac
molecul
respons
viru
attach
competit
experi
design
sa
residu
enzymat
remov
surfac
cell
cell
grown
coverslip
h
wash
twice
pb
incub
min
c
type
ii
neuraminidas
na
muml
vibrio
cholera
sigmaaldrich
poznan
poland
nacetylneuramin
acid
mm
sigmaaldrich
poznan
poland
heparan
sulfat
hs
galactos
gal
mm
glucos
glu
mm
mannos
man
mm
nacetyldglucosamin
nac
mm
pb
follow
incub
cell
cool
wash
thrice
icecold
pb
overlaid
viral
stock
case
viru
addit
preincub
compound
h
c
adsorpt
sugar
moieti
hs
na
present
adsorpt
cell
incub
h
c
wash
twice
icecold
pb
fix
formaldehyd
analysi
carri
flow
cytometri
confoc
microscopi
fix
cell
permeabil
use
rt
min
bioshop
unspecif
bind
site
block
use
bovin
serum
albumin
pb
c
overnight
prior
stain
visual
virus
anticoronaviru
antibodi
strain
h
rt
merck
warsaw
poland
coupl
goat
antimous
alexa
fluor
antibodi
h
rt
thermo
fisher
scientif
warsaw
poland
use
incub
antibodi
cell
wash
thrice
pb
nuclear
dna
stain
dapi
sigmaaldrich
poznan
poland
stain
coverslip
mount
glass
slide
prolong
diamond
medium
thermo
fisher
scientif
warsaw
poland
fluoresc
imag
acquir
use
zeiss
lsm
confoc
microscop
carl
zeiss
microscopi
gmbh
poznan
poland
flow
cytometri
analysi
cell
permeabil
pb
min
rt
block
bovin
serum
albumin
pb
h
rt
prior
stain
virus
visual
use
anticoronaviru
antibodi
strain
h
rt
merck
warsaw
poland
coupl
goat
antimous
alexa
fluor
antibodi
h
rt
thermo
fisher
scientif
warsaw
poland
stain
cell
scratch
glass
pb
prior
analysi
minimum
cell
per
sampl
analyz
cell
gate
shown
figur
determin
whether
certain
protein
sugar
moieti
may
serv
entri
receptor
cell
monolay
wash
pb
incub
one
follow
compound
na
muml
hs
mm
gal
mm
glu
mm
man
mm
nac
mm
polyclon
rabbit
antihla
abc
antibodi
santa
cruz
min
c
three
wash
except
hs
treat
cell
cell
infect
virus
tcid
per
millilit
moi
presenc
test
agent
control
media
na
treatment
repeat
everi
h
day
sampl
collect
h
unbound
virion
wash
cell
cultur
presenc
compound
condit
appropri
viru
see
viral
stock
section
detail
antibodi
specif
confirm
isotyp
control
antibodi
use
concentr
day
pi
supernat
collect
total
rna
isol
use
viral
dnarna
kit
biotechnolog
gdynia
poland
time
point
select
base
replic
curv
three
virus
figur
revers
transcript
carri
high
capac
cdna
revers
transcript
kit
thermo
fisher
scientif
warsaw
poland
accord
manufactur
protocol
serial
dilut
quantifi
dna
fragment
correspond
viral
n
gene
clone
instaclon
pcr
clone
kit
thermo
fisher
scientif
warsaw
poland
plasmid
use
standard
concentr
linear
form
plasmid
assess
use
spectrophotomet
puriti
confirm
gel
electrophoresi
subsequ
pcr
perform
use
kapa
probe
fast
qpcr
master
mix
kapa
biosystem
rox
use
refer
dye
amplif
program
specif
probe
primer
viru
list
tabl
test
whether
recoveri
sa
neuraminidasemedi
desialyl
affect
viru
attach
appropri
experi
design
cell
grown
coverslip
wash
twice
pb
incub
min
c
muml
na
subsequ
cell
cultur
wash
pb
treat
mm
monophosphonacetylneuramin
acid
sigmaaldrich
poznan
poland
either
pasteurella
multocida
sigmaaldrich
poznan
poland
photobacterium
damsel
sigmaaldrich
poznan
poland
vari
concentr
h
c
follow
treatment
cell
wash
thrice
icecold
pb
infect
iodixanol
concentr
crcov
bcov
h
c
unbound
virion
wash
pb
cell
fix
formaldehyd
activ
neuraminidas
sialyltransferas
verifi
specif
fluorescein
label
maackia
amurensi
lectin
vector
lab
specif
label
sambucu
nigra
lectin
vector
lab
experi
perform
least
three
time
triplic
graph
present
work
creat
use
graphpad
prism
softwar
distribut
valu
test
use
shapirowilk
normal
test
equal
group
varianc
examin
browneforsyth
test
depend
result
test
oneway
anova
dunnett
multipl
comparison
test
kruskalw
test
dunn
multipl
comparison
test
unpair
test
welch
correct
use
p
valu
consid
signific
one
asterisk
identifi
adjust
p
valu
two
asterisk
identifi
adjust
p
valu
three
asterisk
identifi
adjust
p
valu
four
asterisk
identifi
adjust
p
valu
imag
obtain
confoc
microscop
deconvolv
use
autoqu
softwar
process
imagej
fiji
data
obtain
fac
analysi
collect
use
bd
cell
quest
pro
softwar
analyz
use
flowjo
hoek
isol
amsterdam
obtain
describ
author
grate
volker
thiel
provid
isol
hae
cell
obtain
airway
specimen
resect
patient
silesian
center
heart
diseas
follow
written
inform
consent
subject
particip
studi
procedur
acquisit
carri
accord
protocol
approv
bioethic
committe
medic
univers
silesia
katowic
poland
approv
date
februari
anim
procedur
agreement
guidelin
institut
anim
care
use
committe
iacuc
whole
studi
approv
local
iacuc
institut
pharmacolog
polish
academi
scienc
anim
procedur
compli
act
protect
anim
use
scientif
educ
purpos
date
januari
implement
direct
european
parliament
council
date
septemb
number
betacoronavirus
includ
bcov
thought
use
sa
entri
receptor
previou
observ
suggest
role
molecul
may
differ
report
literatur
therefor
perform
seri
experi
examin
receptor
usag
first
perform
hemagglutin
assay
verifi
whether
two
virus
close
relat
crcov
interact
moieti
shown
figur
three
virus
agglutin
mous
erythrocyt
rich
sa
next
determin
import
sa
crcov
bcov
attach
treat
cell
neuraminidas
na
remov
sa
residu
prior
infect
examin
viral
attach
remov
sa
reduc
attach
three
virus
strongest
effect
observ
crcov
decreas
respect
figur
bcov
crcov
agglutin
erythrocyt
repres
pictur
hemagglutin
assay
result
shown
mous
erythrocyt
suspens
mix
viral
stock
incub
room
temperatur
h
influenza
report
hemagglutin
erythrocyt
bind
sialic
acid
sa
use
control
sampl
determin
role
sa
crcov
bcov
entri
treat
cell
neuraminidas
na
prior
infect
examin
viral
replic
remov
sa
na
effect
viral
replic
figur
data
present
mean
sd
least
three
experi
triplic
p
p
p
p
ensur
obtain
result
valid
reconstitut
sa
cell
surfac
incomplet
scission
sa
na
affect
outcom
infect
carri
presenc
solubl
sa
prior
infect
role
sa
viru
attach
lack
effect
replic
confirm
three
virus
figur
expos
incub
h
temperatur
optim
particular
viru
subsequ
unbound
virion
wash
cell
incub
day
presenc
data
present
mean
sd
viru
yield
cell
cultur
supernat
rtqpcr
least
three
experi
triplic
p
p
p
p
confirm
observ
effect
saspecif
strip
restor
sa
cell
surfac
first
cell
treat
na
remov
sa
cell
incub
h
c
presenc
mm
monophosphonacetylneuramin
acid
sodium
salt
compound
activ
verifi
use
specif
lectin
figur
figur
activ
neuraminidas
sialyltransferas
cell
treat
type
ii
neuraminidas
na
muml
overlaid
presenc
mm
monophosphonacetylneuramin
acid
h
c
follow
treatment
cell
fix
sa
visual
sambucu
nigra
lectin
specif
label
fluorescein
green
maackia
amurensi
lectin
specif
label
red
scale
bar
data
collect
minimum
field
view
least
three
differ
sampl
b
graph
present
correct
total
cell
fluoresc
calcul
subtract
product
multipli
cell
surfac
mean
background
fluoresc
total
cell
fluoresc
data
present
mean
sd
least
one
hundr
cell
per
condit
p
p
p
p
examin
viru
attach
control
cell
cell
strip
sa
cell
sa
shield
restor
restor
sa
rescu
cell
surfac
bind
virus
figur
crcov
show
clear
prefer
moieti
figur
bound
preferenti
moieti
figur
similar
bcov
bound
preferenti
much
lower
extent
figur
result
confirm
three
virus
requir
sa
attach
crcov
show
prefer
bcov
previous
report
mdck
cell
line
graph
show
median
fluoresc
normal
control
data
present
mean
sd
least
three
experi
triplic
p
p
p
p
discov
sa
serv
entri
receptor
examin
candid
one
protein
report
facilit
entri
hla
molecul
therefor
block
interact
viru
hlai
molecul
use
polyclon
antibodi
effect
replic
howev
block
infect
crcov
bcov
suggest
hlai
serv
entri
receptor
virus
figur
even
though
remov
sa
cell
surfac
result
potent
inhibit
viral
attach
cell
surfac
effect
complet
therefor
examin
role
hs
sugar
moieti
galactos
glucos
mannos
nacetyldglucosamin
viru
attach
entri
hs
mark
effect
crcov
bcov
inhibit
pronounc
bcov
hs
hs
lesser
extent
crcov
hs
figur
signific
effect
replic
virus
figur
among
sugar
test
nac
alon
show
slight
inhibitori
effect
attach
effect
crcov
bcov
data
shown
optim
temperatur
subsequ
unbound
virion
wash
cell
incub
optim
temperatur
presenc
hs
viru
yield
assess
rtqpcr
day
pi
data
present
mean
sd
least
three
experi
triplic
p
p
p
p
test
possibl
observ
specif
result
adapt
cell
cultur
examin
differ
cell
attach
entri
laboratori
clinic
strain
worth
rememb
laboratori
strain
lost
abil
infect
human
airway
epithelium
clinic
strain
replic
cell
line
perform
seri
experi
clinic
strain
use
infect
hae
cultur
neither
hs
competit
specif
blockad
hlai
sugar
bind
moieti
affect
viral
replic
suggest
molecul
play
role
cell
entri
howev
supplement
solubl
sa
result
dosedepend
reduct
replic
impli
sa
role
entri
process
also
clinic
strain
figur
furthermor
found
sa
hs
effect
adhes
hae
cultur
figur
c
date
studi
betacoronaviru
entri
show
high
variabl
term
receptor
use
cell
attach
entri
make
exampl
sarscov
use
angiotensinconvert
enzym
type
integr
transmembran
protein
entri
receptor
may
also
util
ctype
lectin
receptor
express
dendrit
cell
dcsign
dcsignrel
molecul
lsign
vimentin
hand
merscov
also
infect
human
respiratori
tract
epithelium
employ
dipeptidyl
peptidas
enter
cell
nonhuman
betacoronavirus
exploit
divers
molecul
mhv
neural
cell
adhes
molecul
porcin
hemagglutin
encephalomyel
coronaviru
sa
believ
use
sa
attach
entri
receptor
also
report
employ
hlai
enter
cell
bcov
extens
studi
context
sa
usag
model
base
chicken
mous
rat
erythrocyt
hemagglutin
mdck
cell
line
entri
replic
confirm
role
sa
attach
bcov
inform
role
moieti
cell
entri
avail
crcov
receptor
remain
unknown
check
whether
crcov
bcov
interact
sa
first
hemagglutin
assay
yield
posit
result
case
made
effort
establish
exact
role
moieti
viruscel
interact
three
case
deplet
sa
target
cell
well
blockad
viru
sa
interact
use
solubl
neuramin
acid
strong
effect
viru
bind
prove
moieti
serv
attach
receptor
reconstitut
sa
cell
surfac
enzymat
remov
reveal
crcov
bind
preferenti
sa
sa
contrast
use
rather
consist
publish
literatur
although
prefer
bcov
similar
less
pronounc
suggest
possibl
role
molecul
viru
attach
cell
apart
nacetylneuramin
acid
nglycolylneuramin
acid
also
present
mammalian
cell
surfac
deriv
consequ
activ
citidin
monophosph
nacetylneuramin
acid
hydroxylas
cmah
due
delet
cmah
gene
human
cell
depriv
although
commonli
believ
prevail
nonhuman
anim
cell
current
avail
literatur
show
dog
ocular
mucin
erythrocyt
western
breed
rich
rather
besid
also
known
bovin
express
tissu
domin
human
respiratori
tract
prefer
surpris
worth
stress
abund
ciliat
epitheli
cell
line
crcov
role
cird
develop
disrupt
ciliari
clearanc
one
earli
hallmark
diseas
interest
bakker
et
al
recent
report
loss
hemagglutininesteras
mediat
sa
bind
adapt
human
tissu
suggest
observ
attach
mediat
spike
protein
role
sa
adhes
three
betacoronavirus
unquestion
made
effort
check
whether
moieti
may
also
serv
attach
receptor
virus
blockad
virussa
interact
case
inhibit
viru
attach
pronouncedli
incomplet
test
one
solubl
hs
hamper
attach
three
betacoronavirus
sever
affect
replic
pronounc
effect
note
weakest
crcov
affin
hs
previous
describ
emerg
adapt
cell
cultur
therefor
one
may
assum
observ
effect
would
valid
wildtyp
viru
uniqu
opportun
test
hypothesi
viru
replic
vitro
use
fulli
differenti
hae
cultur
standard
cell
line
show
attach
clinic
strain
depend
markedli
hs
abil
bind
hs
like
relat
cell
cultur
adapt
cell
constitut
exist
model
crcov
infect
vitro
decid
studi
crcov
bcov
vitro
cell
consequ
one
rule
possibl
attach
receptor
specif
may
also
alter
due
cell
cultur
adapt
sa
appear
import
viru
bind
cell
surfac
essenti
entri
crcov
bcov
importantli
clinic
strain
appear
employ
molecul
adhes
entri
receptor
solubl
sa
block
attach
entri
viru
human
airway
epithelium
deplet
sa
neuraminidas
mildli
affect
viru
attach
entri
believ
due
incomplet
remov
sa
abil
cell
reconstitut
sa
surfac
experiment
set
result
show
sa
serv
entri
receptor
crcov
bcov
aim
identifi
molecul
facilit
cell
entri
virus
studi
conduct
show
hla
serv
entri
receptor
rd
hcnla
cell
recent
studi
show
also
act
entri
receptor
find
howev
confirm
research
group
examin
role
hlai
receptor
three
betacoronavirus
found
play
role
cell
entri
laboratori
clinic
strain
howev
replic
bcov
crcov
hamper
presenc
hlaspecif
antibodi
show
virus
employ
hlai
entri
receptor
hla
class
molecul
structur
consist
three
chain
link
microglobulin
molecul
membran
proxim
end
form
domain
adopt
standard
immunoglobulinlik
fold
consequ
belong
immunoglobulin
superfamili
interestingli
superfamili
also
includ
serv
receptor
mhv
farfetch
presumpt
assum
cousin
mhvcrcov
bcovus
structur
similar
molecul
entri
receptor
despit
similar
betacoronavirus
level
protein
sequenc
rang
surfac
molecul
recogn
prevail
opinion
form
separ
genera
character
narrow
host
rang
howev
recent
report
regard
outbreak
among
wild
chimpanze
suggest
betacoronavirus
may
undergo
recurr
interspeci
transmiss
consid
previou
report
one
may
conclud
three
betacoronavirus
frequent
cross
speci
boundari
lead
recombin
emerg
intermedi
form
three
virus
replic
human
cell
scenario
realist
howev
epidemiolog
studi
need
confirm
hypothesi
one
may
also
specul
separ
bcov
realli
occur
lineag
belong
singl
speci
abl
infect
number
differ
host
hand
also
possibl
hlai
specif
relat
cell
cultur
adapt
summar
show
three
close
relat
betacoronavirus
bcov
crcov
util
sa
hs
attach
cell
surfac
target
cell
howev
show
differ
prefer
moieti
import
interact
debat
hlai
molecul
serv
entri
receptor
crcov
bcov
sa
carri
role
fund
work
support
grant
nation
scienc
center
kp
kp
would
like
acknowledg
network
contribut
cost
action
challeng
organ
synthes
inspir
naturefrom
natur
product
chemistri
drug
discoveri
faculti
biochemistri
biophys
biotechnolog
jagiellonian
univers
beneficiari
structur
fund
european
union
grant
molecular
biotechnolog
health
faculti
biochemistri
biophys
biotechnolog
jagiellonian
univers
partner
lead
nation
research
center
support
ministri
scienc
higher
educ
republ
poland
